LGC
Who owns LGC?
LGC is a British MedTech company, currently owned by Cinven since 2020 and 2 other investors. It changed hands in 2015, when Bridgepoint sold.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Key facts
- ·Co-held by KKR, Cinven and Astorg since 2015.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected
Bridgepoint sold LGC to KKR in 2015 after 5 years.
More from Cinven Seventh Fund
Other portfolio companies in the same fund.
UK· 2023UK· 2023UK· 2023
Italy· 2022UK· 2022
UK· 2022More PE-backed in MedTech
Comparable medtech deals from other GPs.
US
GermanyQuestions
Who owns LGC?
LGC is currently owned by Cinven, Astorg and 1 other, through Cinven Seventh Fund, since 2020.
When did Cinven and 2 others acquire LGC?
Cinven and 2 others acquired LGC in 2020.
Who did LGC sell to?
Bridgepoint sold LGC to KKR in 2015 (Secondary).
Who has owned LGC over time?
LGC has been through 4 private-equity ownership periods: Bridgepoint · via Europe IV (BE IV) · 2010–2015 · sold to KKR · (Secondary); KKR · since 2015; Cinven · via Cinven Seventh Fund · since 2020; Astorg · via Astorg VII · since 2020.